NM_006329.4:c.212G>A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_006329.4(FBLN5):​c.212G>A​(p.Arg71Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000192 in 1,613,846 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R71W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000019 ( 0 hom. )

Consequence

FBLN5
NM_006329.4 missense

Scores

5
9
4

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts P:1U:3

Conservation

PhyloP100: 4.07

Publications

7 publications found
Variant links:
Genes affected
FBLN5 (HGNC:3602): (fibulin 5) The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq, Jul 2008]
FBLN5 Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal dominant 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • cutis laxa, autosomal recessive, type 1A
    Inheritance: AR, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Genomics England PanelApp
  • Charcot-Marie-Tooth disease, demyelinating, IIA 1H
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • demyelinating hereditary motor and sensory neuropathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • macular degeneration, age-related, 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • autosomal dominant cutis laxa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensorimotor neuropathy with hyperelastic skin
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive cutis laxa type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006329.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FBLN5
NM_006329.4
MANE Select
c.212G>Ap.Arg71Gln
missense
Exon 4 of 11NP_006320.2
FBLN5
NM_001384158.1
c.335G>Ap.Arg112Gln
missense
Exon 5 of 12NP_001371087.1G3XA98
FBLN5
NM_001384159.1
c.263G>Ap.Arg88Gln
missense
Exon 4 of 11NP_001371088.1G3V4U0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FBLN5
ENST00000342058.9
TSL:1 MANE Select
c.212G>Ap.Arg71Gln
missense
Exon 4 of 11ENSP00000345008.4Q9UBX5
FBLN5
ENST00000267620.14
TSL:1
c.335G>Ap.Arg112Gln
missense
Exon 5 of 12ENSP00000267620.10G3XA98
FBLN5
ENST00000556154.5
TSL:1
c.263G>Ap.Arg88Gln
missense
Exon 4 of 11ENSP00000451982.2G3V4U0

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
151956
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000484
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.0000201
AC:
5
AN:
248976
AF XY:
0.00000742
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000449
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000192
AC:
28
AN:
1461890
Hom.:
0
Cov.:
32
AF XY:
0.0000124
AC XY:
9
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.0000224
AC:
1
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000216
AC:
24
AN:
1112010
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
151956
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74214
show subpopulations
African (AFR)
AF:
0.0000484
AC:
2
AN:
41344
American (AMR)
AF:
0.00
AC:
0
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68004
Other (OTH)
AF:
0.000480
AC:
1
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000386
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
1
-
Macular degeneration, age-related, 3 (2)
-
1
-
Age-related macular degeneration (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.29
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.079
T
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.94
D
M_CAP
Uncertain
0.10
D
MetaRNN
Uncertain
0.51
D
MetaSVM
Uncertain
0.51
D
MutationAssessor
Uncertain
2.1
M
PhyloP100
4.1
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.5
N
REVEL
Uncertain
0.61
Sift
Uncertain
0.019
D
Sift4G
Benign
0.10
T
Polyphen
1.0
D
Vest4
0.73
MutPred
0.43
Gain of catalytic residue at L108 (P = 9e-04)
MVP
0.93
MPC
1.2
ClinPred
0.52
D
GERP RS
5.6
Varity_R
0.35
gMVP
0.86
Mutation Taster
=5/95
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121434300; hg19: chr14-92403458; COSMIC: COSV50902245; COSMIC: COSV50902245; API